SULFONYL
Sulfonylurea Screen, Quantitative
EPIC Test Procedure Code: LAB3716
Synonyms:
Hypoglycemic Agent Screen
HYPOG
Performing Lab:
Referral Laboratory
Patient Preparation:
Specimen must be collected during an episode of hypoglycemia.
Container Type:
Plain red top (NO GEL TUBES)
Specimen Type:
Serum
Preferred Volume:
1.5 mL
Minimum Volume:
0.5 mL
Specimen Processing:
Separate the serum or plasma from the cells within 2 hours of collection and transfer to a plastic transport tube.
Store and Transport:
Frozen
Stability:
Frozen -28 days
Refrigerated -28 days
Room temperature - 7 days
Unacceptable Condition:
Gel tubes are not allowed.
CPT Codes:
80377 - Sulfonylurea Screen Qt (EAP 30021507)
(If billing Medicare, use G0480)
Test Schedule:
Monday, Wednesday, Friday
Turnaround Time:
3-7 days
Method:
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Test Includes:
Drugs detected by this procedure are:
-The first-generation sulfonylureas: chlorpropamide (Diabinese), tolazamide, and tolbutamide (Orinase)
-The second-generation sulfonylureas: glimepiride (Amaryl), glipizide (Glucotrol), and glyburide (Glibenclamide)
-The meglitinides: repaglinide (Prandin) and nateglinide (Starlix)
-The thiazolidinediones: pioglitazone (Actos) and rosiglitazone (Avandia)
-The first-generation sulfonylureas: chlorpropamide (Diabinese), tolazamide, and tolbutamide (Orinase)
-The second-generation sulfonylureas: glimepiride (Amaryl), glipizide (Glucotrol), and glyburide (Glibenclamide)
-The meglitinides: repaglinide (Prandin) and nateglinide (Starlix)
-The thiazolidinediones: pioglitazone (Actos) and rosiglitazone (Avandia)